SRNE Historical PE Ratio image   This SRNE PE ratio history page last updated 11/14/2022
SRNE Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/8/2022
1.47-0.20-0.80NA
Q2 2022
8/15/2022
2.75-0.54-2.16NA
Q1 2022
5/6/2022
1.52-0.12-0.48NA
Q4 2021
3/11/2022
2.18-0.47-1.88NA
Q3 2021
11/5/2021
6.62-0.40-1.60NA
Q2 2021
8/6/2021
8.39-0.57-2.28NA
Q1 2021
5/5/2021
7.320.010.04183.0
Q4 2020
2/19/2021
13.15-0.25-1.00NA
Q3 2020
11/9/2020
5.76-0.33-1.32NA
Q2 2020
8/4/2020
12.84-0.36-1.44NA
Q1 2020
5/11/2020
2.80-0.36-1.44NA
Q4 2019
3/3/2020
2.10-0.41-1.64NA
Q3 2019
11/12/2019
1.61-0.50-2.00NA
Q2 2019
8/9/2019
2.14-0.47-1.88NA
Q1 2019
5/14/2019
3.81-0.88-3.52NA
Q4 2018
3/15/2019
2.33-0.41-1.64NA
Q3 2018
11/9/2018
3.67-0.40-1.60NA
Q2 2018
8/9/2018
5.45-0.73-2.92NA
Q1 2018
5/10/2018
7.35-0.38-1.52NA
Q4 2017
3/16/2018
7.750.180.7210.8
Q3 2017
11/9/2017
2.600.441.761.5
Q2 2017
8/9/2017
1.75-0.20-0.80NA
Q1 2017
5/15/2017
1.68-0.45-1.80NA
Q4 2016
3/22/2017
4.15-0.30-1.20NA
Q3 2016
11/10/2016
5.90-0.20-0.80NA
Q2 2016
8/8/2016
6.85-0.28-1.12NA
SRNE PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/8/2022
1.47-0.20-0.86NA
Q2 2022
8/15/2022
2.75-0.54-1.13NA
Q1 2022
5/6/2022
1.52-0.12-1.56NA
Q4 2021
3/11/2022
2.18-0.47-1.43NA
Q3 2021
11/5/2021
6.62-0.40-1.21NA
Q2 2021
8/6/2021
8.39-0.57-1.14NA
Q1 2021
5/5/2021
7.320.01-0.93NA
Q4 2020
2/19/2021
13.15-0.25-1.30NA
Q3 2020
11/9/2020
5.76-0.33-1.46NA
Q2 2020
8/4/2020
12.84-0.36-1.63NA
Q1 2020
5/11/2020
2.80-0.36-1.74NA
Q4 2019
3/3/2020
2.10-0.41-2.26NA
Q3 2019
11/12/2019
1.61-0.50-2.26NA
Q2 2019
8/9/2019
2.14-0.47-2.16NA
Q1 2019
5/14/2019
3.81-0.88-2.42NA
Q4 2018
3/15/2019
2.33-0.41-1.92NA
Q3 2018
11/9/2018
3.67-0.40-1.33NA
Q2 2018
8/9/2018
5.45-0.73-0.49NA
Q1 2018
5/10/2018
7.35-0.380.04183.8
Q4 2017
3/16/2018
7.750.18-0.03NA
Q3 2017
11/9/2017
2.600.44-0.51NA
Q2 2017
8/9/2017
1.75-0.20-1.15NA
Q1 2017
5/15/2017
1.68-0.45-1.23NA
Q4 2016
3/22/2017
4.15-0.30NANA
Q3 2016
11/10/2016
5.90-0.20NANA
Q2 2016
8/8/2016
6.85-0.28NANA
Quotes delayed 20 minutes

Email EnvelopeFree SRNE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sorrento Therapeutics (SRNE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SRPT PE Ratio History
SRRA PE Ratio History
SRRK PE Ratio History
SRTS PE Ratio History
SSKN PE Ratio History
STAA PE Ratio History
STAB PE Ratio History
STE PE Ratio History
STIM PE Ratio History
STOK PE Ratio History
How should the SRNE historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Sorrento Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this SRNE Historical PE Ratio page.

What is the average historical PE for SRNE based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The SRNE historical PE ratio using the annualized quarterly earnings method works out to 65.1.

What is the average historical PE for SRNE based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The SRNE historical PE ratio using the TTM earnings method works out to 183.8.

On this page we presented the SRNE Historical PE Ratio information for Sorrento Therapeutics' stock. The average SRNE historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 65.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SRNE historical PE based on this TTM earnings result method is 183.8. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SRNE historical PE result, against the recent PE: when this page was posted on 11/11/2022, the most recent closing price for SRNE had been 1.83, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to 0.04. From these numbers, we calculate the recent SRNE PE on 11/11/2022 based on annualized quarterly EPS was 45.8. Based on SRNE's history, that recent PE is low relative to the historical average, with the recent PE 29.6% lower than the historical average PE across our data set for Sorrento Therapeutics. Looking at the recent SRNE PE on 11/11/2022 based on TTM EPS, we calculate the ratio at 45.8. Based on SRNE's history, that recent PE is low relative to the historical average, with the recent PE 75.1% lower than the average PE across our Sorrento Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on SRNE or any other given stock, valuation analysis for SRNE can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Sorrento Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SRNE. Thanks for visiting, and the next time you need to research SRNE Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of TLTW, AutoZone 13F Filers, Funds Holding GNRX.

 

SRNE Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.